Funded Biotechnology Startups in Denmark
Disclosed deal sizes in this Denmark biotech set show a sharp top-end outlier: Zealand Pharma closed a $1.0B round on 2024-06-25, dwarfing the rest of the…
Disclosed deal sizes in this Denmark biotech set show a sharp top-end outlier: Zealand Pharma closed a $1.0B round on 2024-06-25, dwarfing the rest of the disclosed amounts, where the next-largest figures include $275M (Galecto, 2026-02-10) and $240M (ENZIDIA is listed at $240K, so not comparable; the other large disclosed is ADCendo’s $75M on 2026-04-14), with many rounds far smaller (e.g., $80K at Evaxion Biotech on 2025-06-03). The lower tail is also visibly compressed, with the smallest disclosed amounts at $70K (Women in Life Science Denmark, 2025-10-28) and $60K (none; the next smallest disclosed is $40K at none; closest is $80K), while undisclosed amounts appear multiple times (notably Minerva Imaging on 2025-06-10, Ousia Pharma on 2025-05-06, and others).
The list is geographically concentrated around Copenhagen-area addresses: Copenhagen appears repeatedly (e.g., Curasight A/S on 2026-06-22; Alcolase on 2026-05-18; ADCendo on 2026-04-14; EvodiaBio on 2025-12-19; Zealand Pharma on 2024-06-25), alongside frequent Hovedstaden locations such as Hørsholm, Hellerup, and Lyngby. Temporally, entries span from 2022-03-10 (FluoGuide) through the most recent 2026-06-22 (Curasight A/S).
Most recent rounds
50 of 533 more funded startups
This page shows the 50 most recent rounds (back to Mar 2022). The full 53-company history for this listing is available on a paid plan.
Unlock all 53 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the clear outlier, and how does it compare to the rest of the Denmark biotech list?
Zealand Pharma’s $1.0B round on 2024-06-25 is the only disclosed deal at the billion scale, dwarfing the next-largest disclosed amounts that stay well below it (e.g., Galecto at $275M on 2026-02-10 and Hemab at $157M on 2025-11-02).
Are there identifiable time clusters in the most recent rounds shown?
Yes. Several large announcements cluster in 2026, including $3M (Curasight A/S, 2026-06-22), $2M (Alcolase, 2026-05-18), $75M (ADCendo, 2026-04-14), and $275M (Galecto, 2026-02-10), with multiple additional rounds also appearing throughout 2025 (e.g., SNIPR Biome on 2025-08-07 for $41M).
Which city is most over-represented, and which entries anchor it?
Copenhagen-area entries dominate this list, with Copenhagen listed for Curasight A/S (2026-06-22, $3M), Alcolase (2026-05-18, $2M), ADCendo (2026-04-14, $75M), and EvodiaBio (2025-12-19, $7M), among others. Hovedstaden also shows up frequently with non-Copenhagen addresses like Hørsholm (ExpreS2ion, 2025-10-06, $1M) and Kongens Lyngby (Aquaporin, 2024-04-25, $25M).
How often do deals come in without a disclosed amount, and is that concentrated in any particular period?
Undisclosed amounts appear multiple times, including Minerva Imaging (2025-06-10), Ousia Pharma (2025-05-06), Neurescue (2025-02-17), and Rehaler (2023-06-23). They are distributed across the range shown rather than confined to a single year, such as 2025 (multiple entries) and 2023 (e.g., Rehaler).
What stage pattern stands out when comparing early-stage and later-stage labels in the dataset?
The list includes both early and later stages, but there is clear representation of venture-scale financing: e.g., Series C rounds at ADCendo (2026-04-14, $75M) and Hemab (2025-11-02, $157M), plus other mid-to-late stages like SNIPR Biome’s Series B (2025-08-07, $41M). At the same time, multiple Seed/Pre-Seed entries appear at relatively smaller disclosed levels, such as Aida Oncology (Pre-Seed, 2023-03-01, $530K) and NorFalk (Pre-Seed, 2023-03-01, $530K).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.